IRIS UniCatt

Basso, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.468
EU - Europa 1.789
AS - Asia 1.521
SA - Sud America 293
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 6.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.402
SG - Singapore 787
DE - Germania 654
CN - Cina 349
SE - Svezia 313
IT - Italia 260
BR - Brasile 231
VN - Vietnam 92
FR - Francia 82
GB - Regno Unito 81
IN - India 75
UA - Ucraina 72
FI - Finlandia 71
IE - Irlanda 63
ID - Indonesia 49
RU - Federazione Russa 45
PL - Polonia 36
CA - Canada 33
AR - Argentina 30
HK - Hong Kong 30
TR - Turchia 27
BD - Bangladesh 26
BE - Belgio 24
CI - Costa d'Avorio 23
MX - Messico 22
JP - Giappone 20
NL - Olanda 18
ZA - Sudafrica 17
AT - Austria 14
EC - Ecuador 13
IR - Iran 13
ES - Italia 12
IQ - Iraq 12
LT - Lituania 8
PK - Pakistan 8
CZ - Repubblica Ceca 7
GR - Grecia 6
KR - Corea 6
RO - Romania 5
VE - Venezuela 5
CO - Colombia 4
PY - Paraguay 4
SA - Arabia Saudita 4
TN - Tunisia 4
CL - Cile 3
MA - Marocco 3
PE - Perù 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PT - Portogallo 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.129
Salva come PNG Salva come JPEG
Città #
Ashburn 658
Singapore 454
Chandler 332
Beijing 71
New York 67
Dublin 62
Los Angeles 61
Rome 55
Ann Arbor 52
San Mateo 52
Wilmington 52
Cattolica 45
Dallas 44
Chicago 43
Jacksonville 42
Munich 42
Jakarta 41
Nanjing 41
Helsinki 38
The Dalles 38
Boston 35
Nürnberg 33
Warsaw 32
Dearborn 29
Woodbridge 28
Hanoi 27
Moscow 27
Fairfield 26
Princeton 26
Ho Chi Minh City 25
Hong Kong 25
Matera 24
Abidjan 23
Brussels 23
Milan 22
Hyderabad 21
Nanchang 21
Hefei 20
Houston 20
Marseille 20
Frankfurt am Main 19
Redwood City 19
São Paulo 19
Santa Clara 18
Seattle 18
Izmir 17
Tokyo 17
Boardman 16
Shanghai 15
Augusta 14
Denver 14
Redmond 14
Bremen 13
Falls Church 12
Hangzhou 12
Johannesburg 12
Orem 12
Changsha 11
Montreal 11
Lawrence 10
Leawood 10
Mexico City 10
Phoenix 10
Turku 10
Brooklyn 9
Hebei 9
Kent 9
Mountain View 9
Norwalk 9
Stockholm 9
Toronto 9
Cambridge 8
Chennai 8
London 8
Nuremberg 8
Poplar 8
Amsterdam 7
Atlanta 7
Buffalo 7
Guangzhou 7
Guayaquil 7
Lappeenranta 7
Zhengzhou 7
Ankara 6
Mumbai 6
Potenza 6
Rio de Janeiro 6
San Francisco 6
Vienna 6
Bari 5
Belo Horizonte 5
Buenos Aires 5
Campinas 5
Curitiba 5
Dhaka 5
Fremont 5
Kunming 5
Miami 5
Querétaro 5
Ribeirão Preto 5
Totale 3.373
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 590
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 280
A phase II study of sunitinib in advanced hepatocellular carcinoma 242
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 216
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 209
Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study 185
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 178
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 168
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 164
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 162
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 155
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 139
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 138
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 135
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 129
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 128
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 128
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 128
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 127
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 126
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 119
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 117
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 116
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 115
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 113
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 111
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 110
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 109
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 109
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 106
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 101
Novel epigenetic eight-gene signature predictive of poor prognosis and msi-like phenotype in human metastatic colorectal carcinomas 101
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 100
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 92
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 90
Operator learning curve for transradial liver cancer embolization: Implications for the initiation of a transradial access program 90
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 89
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 84
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 82
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse 69
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 69
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 67
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 66
The interference between oxaliplatin & anti-EGFR therapies: A different hypothesis to explain the 'unexplainable' 66
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 56
New life for retrospective study in the precision oncology era 54
Targeted therapy in advanced gastric carcinoma: The future is beginning 53
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 29
Totale 6.210
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.956
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021138 0 0 0 0 0 12 26 4 25 27 38 6
2021/2022453 37 16 12 64 27 11 7 68 17 37 61 96
2022/2023926 124 125 82 168 42 108 48 76 75 25 32 21
2023/2024862 20 90 28 14 12 71 236 263 2 16 38 72
2024/2025862 16 39 71 37 76 37 33 37 93 96 166 161
2025/20261.728 334 87 187 447 636 37 0 0 0 0 0 0
Totale 6.210